Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin M Dayan

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 9, 2025
Controlled Antenatal Thyroid Screening Study III: Effects of gestational thyroid status on brain microstructureCarolyn B McNabb, Anna Scholz, Laura Bloomfield, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2020
Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptidesRavinder K Singh, Camille Malosse, Joanne Davies, et al.
BMJ Open|April 7, 2018
Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohortVassiliki Bravis, Akaal Kaur, Helen C Walkey, et al.
Diabetologia|June 9, 2018
Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetesWendy E Powell, Stephanie J Hanna, Claire N Hocter, et al.
Gastroenterology|May 3, 2012
Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitisBruce E Sands, William J Sandborn, Tom J Creed, et al.
Archives of Disease in Childhood|June 26, 2024
General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study)Claire Scudder, Julia Townson, Jane Bowen-Morris, et al.
Diabetes|February 13, 2024
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 DiabetesEsther Latres, Carla J Greenbaum, Maria L Oyaski, et al.
Diabetes|April 24, 2012
Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cellsDeborah Kronenberg, Robin R Knight, Megan Estorninho, et al.
The Journal of Clinical Endocrinology and Metabolism|March 27, 2023
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED TrialPeter Taylor, Rathie Rajendram, Stephanie Hanna, et al.
The Lancet. Diabetes & Endocrinology|March 5, 2019
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort studyOnyebuchi E Okosieme, Peter N Taylor, Carol Evans, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|May 9, 2025
Controlled Antenatal Thyroid Screening Study III: Effects of gestational thyroid status on brain microstructureCarolyn B McNabb, Anna Scholz, Laura Bloomfield, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2020
Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptidesRavinder K Singh, Camille Malosse, Joanne Davies, et al.
BMJ Open|April 7, 2018
Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohortVassiliki Bravis, Akaal Kaur, Helen C Walkey, et al.
Diabetologia|June 9, 2018
Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetesWendy E Powell, Stephanie J Hanna, Claire N Hocter, et al.
Gastroenterology|May 3, 2012
Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitisBruce E Sands, William J Sandborn, Tom J Creed, et al.
Archives of Disease in Childhood|June 26, 2024
General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study)Claire Scudder, Julia Townson, Jane Bowen-Morris, et al.
Diabetes|February 13, 2024
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 DiabetesEsther Latres, Carla J Greenbaum, Maria L Oyaski, et al.
Diabetes|April 24, 2012
Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cellsDeborah Kronenberg, Robin R Knight, Megan Estorninho, et al.
The Journal of Clinical Endocrinology and Metabolism|March 27, 2023
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED TrialPeter Taylor, Rathie Rajendram, Stephanie Hanna, et al.
The Lancet. Diabetes & Endocrinology|March 5, 2019
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort studyOnyebuchi E Okosieme, Peter N Taylor, Carol Evans, et al.
Pageof 13